Incretins as a novel therapeutic strategy in patients with diabetes and heart failure. - Wikidata - wikimedia - TriplyDB

Incretins as a novel therapeutic strategy in patients with diabetes and heart failure.

Incretins as a novel therapeutic strategy in patients with diabetes and heart failure.

http://www.wikidata.org/entity/Q38008596

about

Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis Potential Bioactive Compounds from Seaweed for Diabetes Management Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants DPP4 deficiency preserved cardiac function in abdominal aortic banding rats Hospitalisation for heart failure and mortality associated with dipeptidyl peptidase 4 (DPP-4) inhibitor use in an unselected population of subjects with type 2 diabetes: a nested case-control study Saxagliptin Improves Glucose Tolerance but not Survival in a Murine Model of Dilated Cardiomyopathy Associations of dipeptidyl peptidase-4 inhibitors with mortality in hospitalized heart failure patients with diabetes mellitus.Incretin-related drug therapy in heart failure.Coumarins as potential antidiabetic agents.Exploring heart failure events in contemporary cardiovascular outcomes trials in type 2 diabetes mellitus.Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.Anti-diabetic potential of selected Malaysian seaweeds

P2860

Q26740171-19718284-75A9-4115-9BA1-86DA837BA3F4 Q26773030-F3EA5A0B-3C66-4DDE-96B2-5D0C88AFDF5D Q26797339-215A7228-0772-41B6-92B6-9EC882BF8A11 Q28238585-E57775C3-48C7-4590-AF42-3C4EDE00DAB5 Q28538591-EF0E8027-5CA7-49D6-91B5-007324C0664C Q35691976-378AB770-040D-4684-9E03-13E32C6BE74E Q36939647-2473C98D-6D3A-4F3F-BE75-1DA212DE11BC Q37337371-6A865579-29CA-445F-A17A-38DBD2EA3BB8 Q38260853-ACEA8C10-230D-41D4-A7FE-03D0D442C677 Q39413318-8BE83EBA-0EC9-4566-ADDD-F5D8409CA573 Q47214520-6003B07B-E229-466B-89F0-61A2EE9C28E3 Q52673331-18DE5E88-B186-4269-BEA0-3FE05A186834 Q56940876-F6B7D34C-1DE2-4E0D-8E6B-559545332794

P2860

Incretins as a novel therapeutic strategy in patients with diabetes and heart failure.

http://www.wikidata.org/entity/Q38008596

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Incretins as a novel therapeutic strategy in patients with diabetes and heart failure.

@en

type

label

Incretins as a novel therapeutic strategy in patients with diabetes and heart failure.

@en

prefLabel

Incretins as a novel therapeutic strategy in patients with diabetes and heart failure.

@en

P1433

Q38008596-3356F9D8-8685-4BF4-8AB6-7185CA9CA53F

P1476

Q38008596-7E868529-6B49-4679-89D0-0A330A2B3603

P2093

Q38008596-31DDE41B-1DEF-459D-9FE0-5597FD0B69EF

Q38008596-A2506BA9-035C-4341-9763-3EAE75176DB2

P2860

Q38008596-06224522-A900-4896-9516-D7F2EE2861F8

Q38008596-0FB7CA8D-49F0-4EAD-B685-2268D2A91918

Q38008596-146BA9DD-083A-4FA3-83E3-8ED457AA58A8

Q38008596-16EBB84B-0028-4893-BB6E-8B9D83E40062

Q38008596-19F74B2D-99BF-4465-9742-D6F027137DFF

Q38008596-22C5F7AF-1A03-49B6-AFD3-38CFAEE85898

Q38008596-258B962C-3CD2-47A7-B375-D289FE6C7024

Q38008596-2749F7B0-D548-4244-BCDB-F5D5C7CE645D

Q38008596-2B5938CC-B44E-4124-A694-0B4D6371223A

Q38008596-3305073F-3CE5-4802-8A99-615B161EE2AA

P2888

Q38008596-4DCC8DB3-6A8B-4F61-8DEC-06BD5F241375

P304

Q38008596-9F34DB1F-86C6-4017-88C0-5D873C215098

P31

Q38008596-E855B227-F553-4E82-8A5B-DDB9824AD1D0

P356

Q38008596-A78D4C50-4215-4479-B367-0B3A223C4178

P433

Q38008596-D14781FB-A0EA-423E-AB5E-F38BBDFC19A8

P478

Q38008596-DB64933A-A485-4CFF-AA86-AF3AABAF614C

P50

Q38008596-4E806A3D-AD30-45C2-A809-30C12E69EBDF

Q38008596-523F8B10-A5B3-44EE-AFBA-CC90B3004B0F

Q38008596-E22D7D6D-3407-4AD4-9A23-7430883D6938

P577

Q38008596-05738C56-27A9-43E1-A6B0-44A5A4F5FF6C

P698

Q38008596-D9CE7E64-5464-4082-AF8A-1100E66EA8E5

P921

Q38008596-27B89565-B88B-4102-9047-63644B240759

P356

S10741-012-9318-Y

P1433

Heart Failure Reviews

P1476

Incretins as a novel therapeutic strategy in patients with diabetes and heart failure

@en

P2093

L Neyses

http://www.w3.org/2001/XMLSchema#string

M A Khan

http://www.w3.org/2001/XMLSchema#string

P2860

Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

Influence of diabetes mellitus on heart failure risk and outcome

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes

Biology of incretins: GLP-1 and GIP

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

P2888

s10741-012-9318-y

P304

141-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-012-9318-Y

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22570104

http://www.w3.org/2001/XMLSchema#string

P921